改进的心尖肥厚型心肌病诊断标准
研究基于英国生物银行影像亚组4112名健康受试者和489名独立健康志愿者,建立心尖壁厚正常参考范围,并在104例心尖肥厚型心肌病患者中验证。按体表面积标化的心尖最大壁厚上限为5.2至5.6 mm/m²(未标化等效值11 mm),诊断准确性0.94,可识别99%的明显心尖肥厚型心肌病和78%的相对型患者。
要点
- 心尖壁厚需按体表面积标化,正常上限为5.2至5.6 mm/m²(未标化等效值11 mm)。
- 该阈值诊断准确性0.94,识别99%明显型和78%相对型心尖肥厚型心肌病。
- 健康人群中仅3%超过该阈值,支持用于未达现行标准者的诊断。
核心结论
- 按体表面积标化的心尖节段壁厚阈值对检测心尖肥厚高度准确,可增强阅片者诊断未达现行国际标准的心尖肥厚型心肌病的信心。
研究设计与样本
- 研究纳入英国生物银行影像亚组健康受试者4112名和独立健康志愿者489名,以及临床定义的心尖肥厚型心肌病患者104例(明显型72例,相对型32例)。
关键影像表现/征象
- 健康队列中心尖壁厚无临床显著的年龄相关差异。
- 存在性别相关差异,但按体表面积标化后无临床显著性。
- 心尖肥厚节段参考范围仅需按体表面积标化,无需按年龄或性别标化。
- 正常上限取4个心尖节段测量值中最大者,对应健康受试者最大心尖壁厚5.2至5.6 mm/m²。
诊断标准与关键数值
- 心尖最大壁厚上限5.2至5.6 mm/m²(未标化等效值11 mm),诊断准确性0.94。
- 该阈值判定为异常的比例:明显型心尖肥厚型心肌病99%(71/72),相对型78%(25/32)。
- 该阈值判定为异常的比例:英国生物银行受试者3%(122/4112),健康志愿者3%(13/489)。
临床应用与阅片要点
- 测量心尖壁厚时按体表面积标化,以5.2至5.6 mm/m²作为正常上限。
- 对未达现行≥15 mm标准的患者,若标化心尖壁厚超过阈值且伴典型心电图/影像表现,可支持心尖肥厚型心肌病诊断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: There is no acceptable maximum wall thickness (MWT) threshold for diagnosing apical hypertrophic cardiomyopathy (ApHCM), with guidelines referring to ≥15 mm MWT for all hypertrophic cardiomyopathy subtypes. A normal myocardium naturally tapers apically; a fixed diagnostic threshold fails to account for this. Using cardiac magnetic resonance, "relative" ApHCM has been described with typical electrocardiographic features, loss of apical tapering, and cavity obliteration but also with MWT <15 mm.
OBJECTIVES: The authors aimed to define normal apical wall thickness thresholds in healthy subjects and use these to accurately identify ApHCM.
METHODS: The following healthy subjects were recruited: healthy UK Biobank imaging substudy subjects (n = 4,112) and an independent healthy volunteer group (n = 489). A clinically defined disease population of 104 ApHCM subjects was enrolled, with 72 overt (MWT ≥15 mm) and 32 relative (MWT <15 mm but typical electrocardiographic/imaging findings) ApHCM subjects. Cardiac magnetic resonance-derived MWT was measured in 16 segments using a published clinically validated machine learning algorithm. Segmental normal reference ranges were created and indexed (for age, sex, and body surface area), and diagnostic performance was assessed.
RESULTS: In healthy cohorts, there was no clinically significant age-related difference for apical wall thickness. There were sex-related differences, but these were not clinically significant after indexing to body surface area. Therefore, segmental reference ranges for apical hypertrophy required indexing to body surface area only (not age or sex). The upper limit of normal (the largest of the 4 apical segments measured) corresponded to a maximum apical MWT in healthy subjects of 5.2 to 5.6 mm/m2 with an accuracy of 0.94 (the unindexed equivalent being 11 mm). This threshold was categorized as abnormal in 99% (71/72) of overt ApHCM patients, 78% (25/32) of relative ApHCM patients, 3% (122/4,112) of UK Biobank subjects, and 3% (13/489) of healthy volunteers.
CONCLUSIONS: Per-segment indexed apical wall thickness thresholds are highly accurate for detecting apical hypertrophy, providing confidence to the reader to diagnose ApHCM in those not reaching current internationally recognized criteria.
引用
- Hughes RK, Shiwani H, Rosmini S, et al. Improved Diagnostic Criteria for Apical Hypertrophic Cardiomyopathy. JACC Cardiovasc Imaging. 2023. PMID: 37831014. doi:10.1016/j.jcmg.2023.07.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。